Register-based studies utilise information stored in registers. The number of register-based studies is growing both in Finland and internationally.
Using the materials in different registers, it is possible to analyse the effectiveness of various therapies provided by the healthcare system or follow potential adverse effects or the safety of pharmacotherapies in different patient groups.
The number of register-based studies is growing both in Finland and internationally. There is a continuously increasing demand for register-based information because registers provide information on the efficacy of pharmacotherapies which makes it possible to target the limited healthcare resources appropriately and correctly.
By international standards, Finland has exceptionally comprehensive health registers with abundant information on morbidity, for example. At best, this could be a competitive edge for Finland since register studies can attract new research investments in the country. Using the data in the register, the number of clinical trials may also increase as the registers help to identify the patients that are suitable research subjects.
In order to have more register-based studies made here in the future, Finland needs legislation that supports the research environment. Recently adopted by Parliament, the Act on secondary use of social welfare and health data is an important step towards uncomplicated permit processes and data material processing.